Nearly 100 wildfires are currently raging throughout the country, burning more than 2 million acres. The rising frequency of these fires poses a special concern for anesthesiologists—the potential for increased rates of ...
Aug 6, 2024
0
0
A deep learning model performs at the level of an abdominal radiologist in the detection of clinically significant prostate cancer on MRI, according to a study published today in Radiology. The researchers hope the model ...
Aug 6, 2024
0
0
Researchers have identified variants in a gene that influences the likelihood of smokers developing abnormal dreams while taking a medication to help them quit.
Aug 6, 2024
0
1
Scientists have successfully tested a new approach for a malaria vaccine in animal experiments. They used genetically modified malaria parasites that developed normally in the mosquito but at a significantly slower rate in ...
Aug 6, 2024
0
0
Many studies have shown multiple sclerosis (MS) is associated with changes to the bacteria in a person's gut—but the changes reported were all over the map. Now, UConn researchers have analyzed the results of seven studies ...
Aug 6, 2024
0
0
Acute lymphoblastic leukemia (ALL) affects both children and adults, but children have better chances to be cured, with long-term survival rates of over 85% compared to 50%–75% in adults.
Aug 6, 2024
0
1
Almost 2.4 million Americans are thought to suffer from the pain and disability of inflammatory bowel disorder (IBD), a type of autoimmune illness that includes ulcerative colitis and Crohn's disease.
Aug 6, 2024
0
0
Competing on the world stage, Olympic athletes face immense pressure to perform their best and represent their country. Mental health dominated Olympic conversations in 2021 after U.S. gymnast Simone Biles withdrew from the ...
Aug 6, 2024
0
0
Damaris Alvarado-Rodriguez, owner of three Children's Playhouse early childhood education centers, thought it best to do away with statistics in her presentation to tell the story of a growing problem.
Aug 6, 2024
0
0
A research paper has been published in Oncotarget titled, "INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment ...
Aug 6, 2024
0
0
